Liminatus Pharma, Inc. Class A Common Stock
Liminatus Pharma, Inc. Class A Common Stock (LIMN) Stock Technical Analysis & Trading Signals
Live technical indicators, trading signals, and momentum insights for Liminatus Pharma, Inc. Class A Common Stock (NASDAQ:LIMN).
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerLIMN Technical Analysis Summary
Liminatus Pharma, Inc. Class A Common Stock stock currently trades in a neutral range, with no clear dominance from buyers or sellers.
Overall, Liminatus Pharma, Inc. Class A Common Stock remains neutral, with indicators showing mixed momentum.
RSI (14): 35.02
Stochastic %K: 7.91
Williams %R: -82.41
Rate of Change (ROC): -24.89
Takeaway:Liminatus Pharma, Inc. Class A Common Stock shows strong bearish momentum, signaling downside pressure.
MACD: -0.07
ADX: 8.37
ATR (14): 0.05
CCI (14): -109.16
Takeaway:Liminatus Pharma, Inc. Class A Common Stock shows a neutral trend, with weak conviction and limited volatility.
Takeaway:Liminatus Pharma, Inc. Class A Common Stock trades closer to support, showing weaker momentum within bands.
Takeaway:Liminatus Pharma, Inc. Class A Common Stock trades below the trend line, showing weaker momentum inside the channel.
Overall Takeaway:LIMN shows bearish money flow, with sellers dominating volume and vigor.
Bullish Signals
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Technical indicators for Liminatus Pharma, Inc. Class A Common Stock are mixed, suggesting a Hold or wait-and-see approach.